Latest California Healthline Stories
American ‘Stem Cell Tourists’ Don’t Have To Travel Abroad, Study Says
Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.
But the authors caution against concluding that folic acid is ineffective.
FAQ: How The FDA’s New Tobacco Rule Affects Consumers
The FDA expands its purview over all tobacco products — including e-cigarettes, cigars, pipe tobacco — but the new regulatory process could permit many products sold in the U.S. to remain so for up to three years.
FDA Retreats From Recall Of Scope-Cleaning Machines Tied To Outbreaks
After a wave of sometimes-deadly superbug infections, the agency last year ordered a recall of Custom Ultrasonics machines used to disinfect medical scopes. Now, with little explanation, it is backing off.
Reforming Federal Oversight Of Medical Devices Won’t Be Easy
Despite dozens of infections from medical scopes, an agreement on how to fix the FDA’s flawed regulation of the device industry remains elusive.